WallStreetZenWallStreetZen

NASDAQ: SANA
Sana Biotechnology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SANA

Based on 3 analysts offering 12 month price targets for Sana Biotechnology Inc

Min Forecast
$5.00+151.26%
Avg Forecast
$7.67+285.28%
Max Forecast
$11.00+452.76%

Should I buy or sell SANA stock?

Based on 3 analysts offering ratings for Sana Biotechnology Inc.

Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SANA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SANA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their SANA stock forecasts and price targets.

SANA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-24
lockedlocked$00.00+00.00%2025-03-18
lockedlocked$00.00+00.00%2025-03-14

1 of 1

Forecast return on equity

Is SANA forecast to generate an efficient return?

Company
-82.53%
Industry
148.05%
Market
89.88%
SANA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SANA forecast to generate an efficient return on assets?

Company
-38.73%
Industry
39.47%
SANA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SANA earnings per share forecast

What is SANA's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.76
Avg 2 year Forecast
-$0.70
Avg 3 year Forecast
-$0.73

SANA revenue forecast

What is SANA's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$64.2M
Avg 2 year Forecast
$194.2M
Avg 3 year Forecast
$349.4M

SANA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SANA$1.99$7.67+285.28%Strong Buy
MAZE$10.28$25.67+149.68%Strong Buy
ORIC$6.35$18.67+193.97%Strong Buy
VSTM$8.31$12.33+48.41%Strong Buy
CGEM$7.81$30.67+292.66%Strong Buy
View Top Biotech Stocks

Sana Biotechnology Stock Forecast FAQ

Is Sana Biotechnology Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SANA) stock is to Strong Buy SANA stock.

Out of 3 analysts, 1 (33.33%) are recommending SANA as a Strong Buy, 2 (66.67%) are recommending SANA as a Buy, 0 (0%) are recommending SANA as a Hold, 0 (0%) are recommending SANA as a Sell, and 0 (0%) are recommending SANA as a Strong Sell.

If you're new to stock investing, here's how to buy Sana Biotechnology stock.

What is SANA's earnings growth forecast for 2025-2027?

(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.47%.

Sana Biotechnology's earnings in 2025 is -$208,673,000.On average, 6 Wall Street analysts forecast SANA's earnings for 2025 to be -$171,422,088, with the lowest SANA earnings forecast at -$198,488,734, and the highest SANA earnings forecast at -$157,888,765. On average, 6 Wall Street analysts forecast SANA's earnings for 2026 to be -$157,505,321, with the lowest SANA earnings forecast at -$189,466,518, and the highest SANA earnings forecast at -$121,799,905.

In 2027, SANA is forecast to generate -$163,911,094 in earnings, with the lowest earnings forecast at -$234,577,594 and the highest earnings forecast at -$99,244,367.

What is SANA's revenue growth forecast for 2028-2030?

(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 58.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.

Sana Biotechnology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $14,480,655,332, with the lowest SANA revenue forecast at $14,480,655,332, and the highest SANA revenue forecast at $14,480,655,332. On average, 1 Wall Street analysts forecast SANA's revenue for 2029 to be $43,802,854,602, with the lowest SANA revenue forecast at $43,802,854,602, and the highest SANA revenue forecast at $43,802,854,602.

In 2030, SANA is forecast to generate $78,809,049,423 in revenue, with the lowest revenue forecast at $78,809,049,423 and the highest revenue forecast at $78,809,049,423.

What is SANA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SANA) forecast ROA is -38.73%, which is lower than the forecast US Biotechnology industry average of 39.47%.

What is SANA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SANA price target, the average SANA price target is $7.67, with the highest SANA stock price forecast at $11.00 and the lowest SANA stock price forecast at $5.00.

On average, Wall Street analysts predict that Sana Biotechnology's share price could reach $7.67 by Apr 24, 2026. The average Sana Biotechnology stock price prediction forecasts a potential upside of 285.28% from the current SANA share price of $1.99.

What is SANA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SANA) Sana Biotechnology's current Earnings Per Share (EPS) is -$0.88. On average, analysts forecast that SANA's EPS will be -$0.76 for 2025, with the lowest EPS forecast at -$0.88, and the highest EPS forecast at -$0.70. On average, analysts forecast that SANA's EPS will be -$0.70 for 2026, with the lowest EPS forecast at -$0.84, and the highest EPS forecast at -$0.54. In 2027, SANA's EPS is forecast to hit -$0.73 (min: -$1.04, max: -$0.44).

What is SANA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SANA) forecast ROE is -82.53%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.